Make commercial product broadly available in the United States
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 31 Jul 2025
- Due
- 31 Dec 2025
- Delivered
- November 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“commercial product to be broadly available by mid-Q4 2025”
What we found
Evidence strength A What the grades mean
The company confirmed that its commercial product, VIZZ, became broadly available in retail pharmacies beginning in November 2025, meeting the mid-Q4 2025 deadline.
-
A LENZ Therapeutics, Inc. 10-K filed 2026-03-24
“product became broadly available in retail pharmacies beginning in November 2025.” ✓ confirmed on the page
Market reaction: the shares moved -17.2% against the S&P 500 over the three sessions around the disclosure (23 Mar 2026 to 26 Mar 2026). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Make
- Deliverable
- commercial product
- Where
- United States
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you LENZ Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-LENZ-003370 · Corrections policy